Showing results (1201-1210 of 1,506) with videos related to
Sort By:
Pageof 151
Advances in Lipoprotein(A) Research|February 27, 2026
Association of lipoprotein(a), oxidized phospholipids and apolipoprotein B100 in acute ischemic stroke cohortYihao Li, Emmie Then, Salwa Rahman, et al.Cell Reports|August 16, 2016
A Link between Integral Membrane Protein Expression and Simulated Integration EfficiencyStephen S Marshall, Michiel J M Niesen, Axel Müller, et al.Current Biology : CB|May 10, 2000
Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338A Chaudhary, W G King, M D Mattaliano, et al.Health Physics|April 1, 1994
Radon in outdoor air in NevadaJ G Price, J G Rigby, L Christensen, et al.BMC Cardiovascular Disorders|August 25, 2017
Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islander adultsMarc G W Rémond, Simon Stewart, Melinda J Carrington, et al.Vaccine|February 14, 2017
Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum studyLisa McHugh, Ross M Andrews, Stephen B Lambert, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 23, 2018
Carotid revascularization and medical management for asymptomatic carotid stenosis - Hemodynamics (CREST-H): Study design and rationaleRandolph S Marshall, Ronald M Lazar, David S Liebeskind, et al.Clinical Lymphoma, Myeloma & Leukemia|May 19, 2026
The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and JapanAaron S Rosenberg, Thomas Chalopin, Alison Bulkley, et al.Human Vaccines & Immunotherapeutics|May 6, 2016
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative processGary S Marshall, Shelly D Senders, Julie Shepard, et al.Pediatrics|July 13, 2022
Value of the Immunization Program for Children in the 2017 US Birth CohortJustin Carrico, Elizabeth M La, Sandra E Talbird, et al.Pageof 151